DAVENPORT & Co LLC reduced its position in shares of argenx SE (NASDAQ:ARGX – Free Report) by 5.1% during the fourth quarter, ...

The strategic decisions we made in 2024 position Johnson & Johnson ... for Nipocalimab for the treatment of generalized myasthenia gravis in addition to the FDA breakthrough therapy and Fast ...

Background: The ability to distinguish between a normal thymus, thymic hyperplasia, and thymoma should aid in clinical management and decision making for patients with myasthenia gravis (MG ... This ...

Myasthenia gravis (MG) does not have stages but classes. These classes describe the muscles the condition affects and the severity of muscle weakness, which can influence the treatments a doctor ...

Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...

THE occurrence of thyrotoxicosis in patients with myasthenia gravis is not rare ... Tests of motor power were made approximately every second day. They were always done in the morning, ten ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

OpenAI recently announced Operator, an AI agent designed to perform tasks on the web. After testing it (yes, I paid the $200 bucks, but, more importantly, I kept the subscription勞), this is a ...

Praised for its potential anti-inflammatory and anti-microbial properties, he detailed how it's made with just two simple items. Through the winter season, it's not unusual to come down with an ...

Phase III Vivacity-MG3 trial shows that nipocalimab, an investigational FcRn blocker, significantly the improves symptoms of generalized myasthenia gravis with a manageable safety profile.